Determining the clinical effectiveness of antiviral drugs against oseltamivir- and laninamivir-resistant influenza viruses in animal models [ 2013 - 2016 ]

Research Grant

Researchers: A/Pr Aeron Hurt (Principal investigator) ,  A/Pr Veronika Von Messling ,  Dr Ian Barr ,  Dr Sebastian Maurer-Stroh ,  Prof Carl Kirkpatrick

Brief description Currently, the neuraminidase inhibitors are the only drugs that are effective against seasonal influenza viruses. However, viruses can develop resistance to these drugs. Using viruses with varied levels of resistance, the project will determine the effectiveness of different drug treatments in animal models. This will lead to better treatment for those patients seriously ill with drug-resistant influenza viruses.

Funding Amount $AUD 388,067.24

Funding Scheme Targeted Calls

Notes A*STAR - Utilising Integrative Technologies to Combat Emerging Infectious Disease